Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.730
-0.110 (-5.98%)
At close: Jul 2, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Jul 2, 2026, 6:42 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $219.85 million as of July 2, 2026. Its market cap has increased by 148.75% in one year.
Market Cap
219.85M
Enterprise Value
152.85M
1-Year Change
148.75%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $219.85M, an increase of 87.85%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 219.85M | -10.74% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 228.19M |
| Whitehawk Therapeutics | 225.35M |
| NervGen Pharma | 225.15M |
| Codexis | 224.51M |
| Coherus Oncology | 223.66M |
| Keros Therapeutics | 222.86M |
| Q32 Bio | 221.96M |
| Karyopharm Therapeutics | 217.56M |